Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations

Adaptimmune Therapeutics plc (ADAP)

1.63   0.17 (11.64%) 08-16 16:00
Open: 1.45 Pre. Close: 1.46
High: 1.78 Low: 1.44
Volume: 322,424 Market Cap: 171M

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 1.783 - 1.793 1.793 - 1.802
Low: 1.418 - 1.429 1.429 - 1.439
Close: 1.612 - 1.63 1.63 - 1.646

Technical analysis

as of: 2019-08-16 4:45:40 PM
Stoxline posted a BUY today, upgraded from lower rating. Upward movement to be expected.
Target: Six months: 3.41     One year: 4.49
Support: Support1: 1.44    Support2: 1.20
Resistance: Resistance1: 2.92    Resistance2: 3.84
Pivot: 2.23
Moving Average: MA(5): 1.61     MA(20): 2.51
MA(100): 3.69     MA(250): 5.69
MACD: MACD(12,26): -0.51     Signal(9): -0.43
Stochastic oscillator: %K(14,3): 3.42     %D(3): 3.47
RSI: RSI(14): 26.65
52-week: High: 14.54  Low: 1.44  Change(%): -80.8
Average Vol(K): 3-Month: 29007  10-Days: 44277

Price, moving averages and Bollinger Bands

Price and moving averages has closed below its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BEARISH in short-term; and BEARISH in mid-long term.
ADAP has closed above bottom band by 25.8%. Bollinger Bands are 117% wider than normal. The large width of the bands suggest high volatility as compared to ADAP's normal range. The bands have been in this wide range for 9 bars. This is a sign that the current trend might continue.

Headline News

Fri, 16 Aug 2019 17:13:04 Z
What's in Store for Aytu BioScience's (AYTU) Q4 Earnings?

Fri, 02 Aug 2019 03:56:49 Z
Adaptimmune Therapeutics (ADAP) Q2 2019 Earnings Call Transcript

Tue, 09 Jul 2019 17:07:17 Z
Athenex (ATNX) in Focus: Stock Moves 6.5% Higher

Tue, 09 Jul 2019 15:17:46 Z
Adaptimmune Therapeutics PLC (ADAP) Upgraded to Strong Buy: Here's Why

Mon, 28 Jan 2019 16:51:24 Z
Adaptimmune Therapeutics PLC (ADAP) Upgraded to Buy: Here's What You Should Know

Financial Analysis

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Click here to get more fundamental analysis.
Tweet this page Share on Facebook
Free Technical Analysis Charts

Stock Basics & Statistics

Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 104.72
Shares Float (M) 48.10
% Held by Insiders 0.22
% Held by Institutions 73.00
Shares Short (K) 3740
Shares Short P. Month (K)

Stock Financials

EPS -0.967
EPS Est. Current Year -0.990
EPS Est. Next Year
EPS Est. Next Quarter -0.250
Forward EPS -1.310
Book Value (p.s.) 1.780
PEG Ratio -1.57
Profit Margin -234.35
Operating Margin -222.45
Return on Assets (ttm) -26.2
Return on Equity (ttm) -56.5
Qtrly Rev. Growth -98.3
Gross Profit (p.s.) -0.370
Sales Per Share
EBITDA (p.s.) -0.825
Qtrly Earnings Growth
Operating Cash Flow (M) -92.12
Levered Free Cash Flow (M) -65.68

Stock Valuations

P/E -1.69
P/E Growth Ratio 0.12
P/BV 0.92
P/S 416325856.00
P/CF -1.85

Dividends & Splits

Dividend Yield
Dividend Pay Date 2018-03-30
Ex-Dividend Date Invalid DateTime.
Forward Dividend
Last Split Date
Last Split Ratio -1e+010
7 Binary Options
Your Ad Here
Stock Chart
Stoxline Lite
Stoxline Pro
Option Calculator
(c) 2006-2019 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.